Evidence map›Paper›PMID 32085562›Full record

ReviewMolecules (Basel, Switzerland)2020

Selected Fungal Natural Products with Antimicrobial Properties.

Dorota Jakubczyk, Francois Dussart

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 116 citations in OpenAlex.

  1. Tandyukisins K-P, New Decalin Polyketides fromAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Mechanism, Efficacy, and Safety of Natural Antibiotics.Antibiotics (Basel, Switzerland) · 2025
    Review
  4. Article
  5. Article
  6. Antimicrobial and cytotoxic activities of natural (Z)-13-docosenamide derived fromFrontiers in cellular and infection microbiology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Dorota JakubczykInstitute of Bioorganic Chemistry, Polish Academy of Sciences, 61-704 Poznań, Poland.
Francois DussartDepartment of Agriculture, Horticulture and Engineering Science, Scotland's Rural College (SRUC), EH9 3JG Edinburgh, UK.
Institute of Bioorganic Chemistry, Polish Academy of Sciences · PLScotland's Rural College · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungal natural products and their effects have been known to humankind for hundreds of years. For example, toxic ergot alkaloids produced by filamentous fungi growing on rye poisoned thousands of people and livestock throughout the Middle Ages. However, their later medicinal applications, followed by the discovery of the first class of antibiotics, penicillins and other drugs of fungal origin, such as peptidic natural products, terpenoids or polyketides, have altered the historically negative reputation of fungal "toxins". The development of new antimicrobial drugs is currently a major global challenge, mainly due to antimicrobial resistance phenomena. Therefore, the structures, biosynthesis and antimicrobial activity of selected fungal natural products are described here.

Indexed as

Antifungal AgentsBiological ProductsFungiMicrobial Sensitivity TestsAntifungal AgentsBiological Productsantimicrobial propertiesantimicrobial resistancebiosynthesisergot alkaloidsfungal metabolitesnatural productspeptidespolyketidesterpenoids

Identifiers

PMID32085562
PMCPMC7070998
OpenAlexW3008013079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.